and need for a revision pelvic fixation (P < .05). Additionally, by Cox regression, initial fixation was a significant predictor of revision (HR, 3.94). A body mass index of >35 kg/m 2 or prior abdominal surgeries were not found to be significant predictors in this case.
Objectives: Lower extremity arteriovenous (AV) access is an option when upper extremity access options have been exhausted. Our goal was to assess short-term outcomes of lower extremity hemodialysis access.
Methods: The Vascular Quality Initiative was reviewed for all lower extremity AV hemodialysis cases. Patient and case details were recorded.
Multivariable analysis was used to analyze outcomes.
Results: We identified 329 lower extremity AV access cases access type was femoral vein straight prosthetic and looped prosthetic in 10.9%, 18.2%, and 70.8%, respectively. The average age was 56.7 6 15.0 years, 47.4% of patients were male, and 42.1% were Caucasian. Comorbidities included hypertension (91.5%), diabetes (48%), obesity (37.9%), nonambulatory (34.7%), congestive heart failure (24%), coronary artery disease (21%), chronic obstructive pulmonary disease (14.9%), current smoking (20.8%), and peripheral arterial disease (14.3%). The majority of patients (89.6%) had previous upper extremity AV access and 23.2% had a prior lower extremity access. More than one-half (56.7%) had a tunneled line at the time of the procedure. Kaplan-Meier analysis showed that the 1-year survival was 79%, the 6-month primary patency was 59.6%, the 6-month freedom from endovascular intervention was 91.9%, and freedom from surgical revision was 89.2%. Multivariable analysis showed that mortality was predicted by age (hazard ratio, 1.03; 95% confidence interval, 1.004 1.046; P ¼ .02). Loss of primary patency was predicted by nonambulatory status (hazard ratio, 1.56; 95% confidence interval, 1.03 2.34; P ¼ .035). Access type did not affect survival, primary patency, or endovascular or surgical reintervention.
Conclusions:
Patients undergoing lower extremity AV access have a high comorbidity burden and low primary patency and survival. Those patients who are older and are nonambulatory are at particularly high risk for poor outcomes. Access type did not affect outcomes. These data provide evidence for perioperative and long-term patient education and planning. Objectives: Although autogenous arteriovenous fistulas provide the best source of prolonged hemodialysis access, up to 30% are fail and require creation of a new access. In some cases, the fistula requires banding to treat symptoms of high flow or steal syndrome. This study describes our first experience with a modification of the MILLER banding technique that allows us to control flow through the fistula and preserve a secondary access, which can be opened endovascularly and used immediately if the primary access fails.
Methods: From 2008 to 2017, in 52 patients a secondary vein was preserved by banding in addition to the creation of a fistula. A coronary artery dilator is placed outside a nonprimary access vein and a Prolene stitch is used to band the vein to the desired size (modified MILLER technique). This banding can be broken in case of primary access failure, and the secondary access can be used immediately without creation of a new AV fistula. Patients were followed for up to 4 years to calculate patency rates. Patients with standard MILLER banding were used as a comparison group.
Results: Primary patency rates at 6 months, and 1, 2, 3, and 4 years were 88%, 72%, 50%, 50%, and 37%, respectively. Primary assisted patency rates at 6 months, a d 1, 2, 3, and 4 years were 96%, 80%, 52%, 52%, and 41%, respectively. These rates were not different than in the comparison group. Stenosis developed in 32 fistulas and thrombosis developed in three fistulas. In one case, after stenosis caused failure of the primary access, the banding was opened and the secondary fistula was used without additional time for maturation. In four patients, a banded basilic vein was used as a secondary construct without breaking the banding after failure of the primary access vein to mature. In three of these patients, brachial artery to translocated basilic vein fistulas were created. In one patient, the primary access vein was ligated and the secondary fistula was functional. Bandings were unintentionally opened four times during angiography.
Conclusions: Modified MILLER banding offers an alternative access for hemodialysis without additional maturation time upon fistula failure. The primary patency and primary assisted patency rates of modified MILLER banding do not differ from patients with MILLER banding.
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PC102. Side Branch Ligation Improves Function of Arteriovenous Fistula
Jessica Rouan, Timothy Wu, Frank Padberg, Joe Huang, Michael Curi. Rutgers University, New Brunswick, NJ Objectives: Arteriovenous fistulae (AVF) for hemodialysis are plagued by a high rate of initial functional failure. Although thrombosis is a common etiology, some AVF may fail owing to flow diversion into side branches. We hypothesized that eliminating these side branches would improve flow in nonmaturing AVF and increase functional patency.
Methods: Nonmaturing AVF were reviewed retrospectively; thrombosed AVF were excluded. AVF were initially assessed at 6 weeks by duplex ultrasound imaging and those with large (>3 mm) or multiple 
